Viking Therapeutics (VKTX 1.70%) is developing VK2735, a dual GLP-1/GIP receptor agonist for obesity treatment. The company ...

The NHS rollout of Wegovy and Mounjaro will be scaled up, the Government has promised – without setting a date for when it ...

A collection of videos, study abstracts, and other resources all focused on disparities in obesity. Obesity is independently ...

Multimodal AOMs were associated with the highest preoperative weight loss among patients with high BMI undergoing bariatric surgery.

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised multidisciplinary treatments, at a cost.

Objectives To compare the odds of depression in obese and overweight children with that in normal-weight children in the community. Design Systematic review and random-effect meta-analysis of ...

Obesity is associated with financial hardship and food insecurity, according to a research letter published online June 24 in ...

A new study compares body mass index (BMI) with body fat percentage and finds the latter is far more reliable in predicting ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

Novo Nordisk executives overlooked warnings ahead of Wegovy's launch, leading to supply issues, high costs, and challenges competing with Eli Lilly's Zepbound.

A new study reports that measurements that detect body fat are a more accurate predictor of mortality risk than body mass ...